| 000 | 01531 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516013744.0 | ||
| 264 | 0 | _c20110418 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a1879-0712 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2010.11.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEl-Azab, Mona | |
| 245 | 0 | 0 |
_aAnti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cFeb 2011 |
||
| 300 |
_a7-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Ehrlich Tumor _xblood |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
| 650 | 0 | 4 | _aNeovascularization, Pathologic |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aStilbenes _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors |
| 700 | 1 | _aHishe, Hailemichael | |
| 700 | 1 | _aMoustafa, Yasser | |
| 700 | 1 | _aEl-Awady, El-Sayed | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 652 _gno. 1-3 _gp. 7-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2010.11.008 _zAvailable from publisher's website |
| 999 |
_c20407554 _d20407554 |
||